当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析 - 现金流量表

上海医药

(601607)

  

流通市值:503.17亿  总市值:668.99亿
流通股本:27.89亿   总股本:37.08亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金70,910,161,157.29301,138,074,959.71216,241,126,794.79143,040,840,673.35
收到的税费返还38,238,102.29157,075,769.86161,365,821.57109,651,206.45
收到其他与经营活动有关的现金1,393,974,548.043,355,474,894.373,014,000,050.911,692,189,000.81
经营活动现金流入的平衡项目0000
经营活动现金流入小计72,342,373,807.62304,650,625,623.94219,416,492,667.27144,842,680,880.61
购买商品、接受劳务支付的现金65,775,005,547.17268,134,361,085.34192,621,520,661.57127,982,487,400.74
支付给职工以及为职工支付的现金2,607,855,464.0410,639,199,652.276,829,300,693.725,633,875,615.09
支付的各项税费1,773,546,369.287,327,044,163.215,770,527,692.33,763,146,129.92
支付其他与经营活动有关的现金4,390,282,030.3412,722,762,991.7911,412,179,163.426,947,868,351.83
经营活动现金流出的平衡项目0000
经营活动现金流出小计74,546,689,410.83298,823,367,892.61216,633,528,211.01144,327,377,497.58
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-2,204,315,603.215,827,257,731.332,782,964,456.26515,303,383.03
二、投资活动产生的现金流量:
收回投资收到的现金15,723,939,00047,809,428,496.4117,454,567,00011,350,000,000
取得投资收益收到的现金38,474,527.841,346,951,721.68971,322,262.61701,767,577.55
处置固定资产、无形资产和其他长期资产收回的现金净额12,714,792.84244,660,546.13159,079,166.98138,689,186.29
处置子公司及其他营业单位收到的现金净额15,892,367.13-12,364,306.65-
收到的其他与投资活动有关的现金667,562,153.291,032,193,865.93756,787,587.49705,238,031.66
投资活动现金流入的平衡项目0000
投资活动现金流入小计16,458,582,841.150,433,234,630.1519,354,120,323.7312,895,694,795.5
购建固定资产、无形资产和其他长期资产支付的现金729,965,333.272,400,874,817.191,835,291,094.21,393,196,297.47
投资支付的现金16,032,179,00045,933,887,00015,857,397,0008,400,000,000
取得子公司及其他营业单位支付的现金18,657,072.8485,292,225.3493,692,695.483,508,582.82
支付其他与投资活动有关的现金650,718,8401,597,200,887.931,209,757,790.34985,812,200
投资活动现金流出的平衡项目0000
投资活动现金流出小计17,431,520,246.1150,017,254,930.4618,996,138,579.9410,862,517,080.29
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-972,937,405.01415,979,699.69357,981,743.792,033,177,715.21
三、筹资活动产生的现金流量:
吸收投资收到的现金7,378,175.786,196,122.618,315,022.813,743,691.91
取得借款收到的现金20,071,815,783.1261,928,229,561.8545,513,265,721.3535,603,636,632.05
发行债券收到的现金2,998,941,666.6711,997,222,500.018,997,610,000.015,998,726,666.67
收到其他与筹资活动有关的现金174,562,727.69137,374,213.51654,648,042.46126,620,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计23,252,698,353.1874,149,022,397.9755,183,838,786.6341,732,726,990.63
偿还债务支付的现金18,625,809,410.4570,102,029,449.9450,540,691,452.4135,828,520,541.97
分配股利、利润或偿付利息支付的现金590,654,622.244,309,892,169.513,431,566,587.41,102,901,126.35
其中:子公司支付给少数股东的股利、利润183,402,958.44706,216,464.59310,114,905.19151,114,751.28
支付其他与筹资活动有关的现金172,025,454.51,601,031,157.181,074,804,786.251,038,205,257.32
筹资活动现金流出平衡项目0000
筹资活动现金流出小计19,388,489,487.1976,012,952,776.6355,047,062,826.0637,969,626,925.64
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额3,864,208,865.99-1,863,930,378.66136,775,960.573,763,100,064.99
四、汇率变动对现金及现金等价物的影响4,038,703.532,156,741.31-22,872,683.73-8,187,361.97
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额690,994,561.34,381,463,793.673,254,849,476.896,303,393,801.26
加:期初现金及现金等价物余额31,881,272,794.8727,499,809,001.227,499,809,001.227,499,809,001.2
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额32,572,267,356.1731,881,272,794.8730,754,658,478.0933,803,202,802.46
补充资料:
净利润-5,870,011,314.88-3,597,363,036.62
资产减值准备-614,373,564.47-36,526,101.71
固定资产和投资性房地产折旧-1,294,305,848.92-604,856,357.33
无形资产摊销-399,940,491.39-198,802,167.05
长期待摊费用摊销-191,100,283.87-85,945,173.34
处置固定资产、无形资产和其他长期资产的损失--187,967,998.85--139,310,426.73
公允价值变动损失--203,853,796.87--114,288,629.44
财务费用-1,837,342,811.14-915,719,792.37
投资损失--593,000,866.77--342,020,635.74
递延所得税--110,038,272.1--69,992,479.12
其中:递延所得税资产减少-89,329,045.05--38,384,896.92
递延所得税负债增加--199,367,317.15--31,607,582.2
存货的减少--2,297,647,988.62-1,335,453,749.85
经营性应收项目的减少--4,041,023,805.03--7,868,733,874.13
经营性应付项目的增加-2,103,001,583.06-1,622,348,664.67
现金的期末余额-31,881,272,794.87-33,803,202,802.46
减:现金的期初余额-27,499,809,001.2-27,499,809,001.2
公告日期2025-04-292025-03-282024-10-302024-08-27
审计意见(境内)标准无保留意见
TOP↑